These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36829233)

  • 1. Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia.
    Palma Medina LM; Babačić H; Dzidic M; Parke Å; Garcia M; Maleki KT; Unge C; Lourda M; Kvedaraite E; Chen P; Muvva JR; Cornillet M; Emgård J; Moll K; ; Michaëlsson J; Flodström-Tullberg M; Brighenti S; Buggert M; Mjösberg J; Malmberg KJ; Sandberg JK; Gredmark-Russ S; Rooyackers O; Svensson M; Chambers BJ; Eriksson LI; Pernemalm M; Björkström NK; Aleman S; Ljunggren HG; Klingström J; Strålin K; Norrby-Teglund A
    Respir Res; 2023 Feb; 24(1):62. PubMed ID: 36829233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-omics analysis reveals overactive inflammation and dysregulated metabolism in severe community-acquired pneumonia patients.
    Li J; Wang Y; Zhao W; Yang T; Zhang Q; Yang H; Li X; Tong Z
    Respir Res; 2024 Jan; 25(1):45. PubMed ID: 38243232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic study revealed cellular assembly and lipid metabolism dysregulation in sepsis secondary to community-acquired pneumonia.
    Sharma NK; Tashima AK; Brunialti MKC; Ferreira ER; Torquato RJS; Mortara RA; Machado FR; Assuncao M; Rigato O; Salomao R
    Sci Rep; 2017 Nov; 7(1):15606. PubMed ID: 29142235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host protease activity classifies pneumonia etiology.
    Anahtar M; Chan LW; Ko H; Rao A; Soleimany AP; Khatri P; Bhatia SN
    Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2121778119. PubMed ID: 35696579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia.
    Schuurman AR; Reijnders TDY; Saris A; Ramirez Moral I; Schinkel M; de Brabander J; van Linge C; Vermeulen L; Scicluna BP; Wiersinga WJ; Vieira Braga FA; van der Poll T
    Elife; 2021 Aug; 10():. PubMed ID: 34424199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.
    ;
    Cell; 2022 Mar; 185(5):916-938.e58. PubMed ID: 35216673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting severity in COVID-19 disease using sepsis blood gene expression signatures.
    Baghela A; An A; Zhang P; Acton E; Gauthier J; Brunet-Ratnasingham E; Blimkie T; Freue GC; Kaufmann D; Lee AHY; Levesque RC; Hancock REW
    Sci Rep; 2023 Jan; 13(1):1247. PubMed ID: 36690713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput mass spectrometry maps the sepsis plasma proteome and differences in patient response.
    Mi Y; Burnham KL; Charles PD; Heilig R; Vendrell I; Whalley J; Torrance HD; Antcliffe DB; May SM; Neville MJ; Berridge G; Hutton P; Geoghegan CG; Radhakrishnan J; Nesvizhskii AI; Yu F; ; Davenport EE; McKechnie S; Davies R; O'Callaghan DJP; Patel P; Del Arroyo AG; Karpe F; Gordon AC; Ackland GL; Hinds CJ; Fischer R; Knight JC
    Sci Transl Med; 2024 Jun; 16(750):eadh0185. PubMed ID: 38838133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting sepsis severity at first clinical presentation: The role of endotypes and mechanistic signatures.
    Baghela A; Pena OM; Lee AH; Baquir B; Falsafi R; An A; Farmer SW; Hurlburt A; Mondragon-Cardona A; Rivera JD; Baker A; Trahtemberg U; Shojaei M; Jimenez-Canizales CE; Dos Santos CC; Tang B; Bouma HR; Cohen Freue GV; Hancock REW
    EBioMedicine; 2022 Jan; 75():103776. PubMed ID: 35027333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reduced proteomic signature in critically ill Covid-19 patients determined with plasma antibody micro-array and machine learning.
    Patel MA; Daley M; Van Nynatten LR; Slessarev M; Cepinskas G; Fraser DD
    Clin Proteomics; 2024 May; 21(1):33. PubMed ID: 38760690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dimensional phenotyping of the peripheral immune response in community-acquired pneumonia.
    Reijnders TDY; Schuurman AR; Verhoeff J; van den Braber M; Douma RA; Faber DR; Paul AGA; Wiersinga WJ; Saris A; Garcia Vallejo JJ; van der Poll T
    Front Immunol; 2023; 14():1260283. PubMed ID: 38077404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential.
    Suvarna K; Biswas D; Pai MGJ; Acharjee A; Bankar R; Palanivel V; Salkar A; Verma A; Mukherjee A; Choudhury M; Ghantasala S; Ghosh S; Singh A; Banerjee A; Badaya A; Bihani S; Loya G; Mantri K; Burli A; Roy J; Srivastava A; Agrawal S; Shrivastav O; Shastri J; Srivastava S
    Front Physiol; 2021; 12():652799. PubMed ID: 33995121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and multiomics profiles indicate coagulation and platelet dysfunction in COVID-19 viral sepsis.
    Xiao Z; Lin M; Song N; Wu X; Hou J; Wang L; Tian X; An C; Dela Cruz CS; Sharma L; Chang D
    iScience; 2024 Jun; 27(6):110110. PubMed ID: 38974472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expression.
    Cano-Gamez E; Burnham KL; Goh C; Allcock A; Malick ZH; Overend L; Kwok A; Smith DA; Peters-Sengers H; Antcliffe D; ; McKechnie S; Scicluna BP; van der Poll T; Gordon AC; Hinds CJ; Davenport EE; Knight JC; Webster N; Galley H; Taylor J; Hall S; Addison J; Roughton S; Tennant H; Guleri A; Waddington N; Arawwawala D; Durcan J; Short A; Swan K; Williams S; Smolen S; Mitchell-Inwang C; Gordon T; Errington E; Templeton M; Venatesh P; Ward G; McCauley M; Baudouin S; Higham C; Soar J; Grier S; Hall E; Brett S; Kitson D; Wilson R; Mountford L; Moreno J; Hall P; Hewlett J; McKechnie S; Garrard C; Millo J; Young D; Hutton P; Parsons P; Smiths A; Faras-Arraya R; Soar J; Raymode P; Thompson J; Bowrey S; Kazembe S; Rich N; Andreou P; Hales D; Roberts E; Fletcher S; Rosbergen M; Glister G; Cuesta JM; Bion J; Millar J; Perry EJ; Willis H; Mitchell N; Ruel S; Carrera R; Wilde J; Nilson A; Lees S; Kapila A; Jacques N; Atkinson J; Brown A; Prowse H; Krige A; Bland M; Bullock L; Harrison D; Mills G; Humphreys J; Armitage K; Laha S; Baldwin J; Walsh A; Doherty N; Drage S; Ortiz-Ruiz de Gordoa L; Lowes S; Higham C; Walsh H; Calder V; Swan C; Payne H; Higgins D; Andrews S; Mappleback S; Hind C; Garrard C; Watson D; McLees E; Purdy A; Stotz M; Ochelli-Okpue A; Bonner S; Whitehead I; Hugil K; Goodridge V; Cawthor L; Kuper M; Pahary S; Bellingan G; Marshall R; Montgomery H; Ryu JH; Bercades G; Boluda S; Bentley A; Mccalman K; Jefferies F; Knight J; Davenport E; Burnham K; Maugeri N; Radhakrishnan J; Mi Y; Allcock A; Goh C
    Sci Transl Med; 2022 Nov; 14(669):eabq4433. PubMed ID: 36322631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Plasma Inflammatory Markers of Adolescent Depression Using the Olink Proteomics Platform.
    Yang L; Cao M; Tian J; Cui P; Ai L; Li X; Li H; Gao M; Fang L; Zhao L; Gong F; Zhou C
    J Inflamm Res; 2023; 16():4489-4501. PubMed ID: 37849645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy-specific responses to COVID-19 are revealed by high-throughput proteomics of human plasma.
    Gomez-Lopez N; Romero R; Escobar MF; Carvajal JA; Echavarria MP; Albornoz LL; Nasner D; Miller D; Gallo DM; Galaz J; Arenas-Hernandez M; Bhatti G; Done B; Zambrano MA; Ramos I; Fernandez PA; Posada L; Chaiworapongsa T; Jung E; Garcia-Flores V; Suksai M; Gotsch F; Bosco M; Than NG; Tarca AL
    Res Sq; 2022 Aug; ():. PubMed ID: 36032966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The landscape of immune dysregulation in pediatric sepsis at a single-cell resolution.
    Alhamdan F; Koutsogiannaki S; Yuki K
    bioRxiv; 2024 Jan; ():. PubMed ID: 38293080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods and clinical biomarker discovery for targeted proteomics using Olink technology.
    Wang H; Zhao T; Zeng J; Zhang R; Pu L; Qian S; Xu S; Jiang Y; Pan L; Dai X; Guo X; Han L
    Proteomics Clin Appl; 2024 May; ():e2300233. PubMed ID: 38726756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-COVID-19 epigenetic signatures.
    Dempsey LA
    Nat Immunol; 2023 Oct; 24(10):1593. PubMed ID: 37735596
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria.
    Mu A; Klare WP; Baines SL; Ignatius Pang CN; Guérillot R; Harbison-Price N; Keller N; Wilksch J; Nhu NTK; Phan MD; Keller B; Nijagal B; Tull D; Dayalan S; Chua HHC; Skoneczny D; Koval J; Hachani A; Shah AD; Neha N; Jadhav S; Partridge SR; Cork AJ; Peters K; Bertolla O; Brouwer S; Hancock SJ; Álvarez-Fraga L; De Oliveira DMP; Forde B; Dale A; Mujchariyakul W; Walsh CJ; Monk I; Fitzgerald A; Lum M; Correa-Ospina C; Roy Chowdhury P; Parton RG; De Voss J; Beckett J; Monty F; McKinnon J; Song X; Stephen JR; Everest M; Bellgard MI; Tinning M; Leeming M; Hocking D; Jebeli L; Wang N; Ben Zakour N; Yasar SA; Vecchiarelli S; Russell T; Zaw T; Chen T; Teng D; Kassir Z; Lithgow T; Jenney A; Cole JN; Nizet V; Sorrell TC; Peleg AY; Paterson DL; Beatson SA; Wu J; Molloy MP; Syme AE; Goode RJA; Hunter AA; Bowland G; West NP; Wilkins MR; Djordjevic SP; Davies MR; Seemann T; Howden BP; Pascovici D; Tyagi S; Schittenhelm RB; De Souza DP; McConville MJ; Iredell JR; Cordwell SJ; Strugnell RA; Stinear TP; Schembri MA; Walker MJ
    Nat Commun; 2023 Mar; 14(1):1530. PubMed ID: 36934086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.